These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4930468)

  • 1. Biochemical research in schizophrenia.
    Boulton AA
    Nature; 1971 May; 231(5297):22-8. PubMed ID: 4930468
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 3. A biochemical study of early infantile austism.
    Himwich HE; Jenkins RL; Fujimori M; Narasimhachari N; Ebersole M
    J Autism Child Schizophr; 1972; 2(2):114-26. PubMed ID: 5068665
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endogenous hallucinogens].
    Kanabus P; Frindt-Zajaczkowska A
    Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients].
    Jus A; Rosengarten H; Wardaszko-Lyskowska H; Szemis A; Stencka K; Wlosińska I; Krzyzowski J; Kowalska K
    Psychiatr Pol; 1970; 4(4):365-71. PubMed ID: 5472573
    [No Abstract]   [Full Text] [Related]  

  • 9. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 11. [The skeleton structure of a hallucinogenic molecule].
    Smythies JR
    Vestn Akad Med Nauk SSSR; 1969; 24(4):41-4. PubMed ID: 5346215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disturbances of tryptophan metabolism during methionine and nialamide administration in chronic schizophrenic patients].
    Rosengarten H; Stencka K; Kowalska K; Wardaszko-Lyskowska H; Szemis A; Wlosińska I; Krzyzowski J; Jus A
    Psychiatr Pol; 1970; 4(3):261-8. PubMed ID: 5459695
    [No Abstract]   [Full Text] [Related]  

  • 13. A biochemical survey of schizophrenia.
    Brodsky L
    Can Psychiatr Assoc J; 1970 Aug; 15(4):375-88. PubMed ID: 4915174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical aspects of schizophrenia].
    van Zwieten PA
    Arzneimittelforschung; 1967 May; 17(5):553-6. PubMed ID: 4873894
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenia, rheumatoid arthritis and trytophan metabolism.
    Taylor WM
    J Clin Psychiatry; 1978 Jun; 39(6):499-503. PubMed ID: 659373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and biochemical alterations in schizophrenic patients.
    Spaide J; Tanimukai H; Bueno JR; Himwich HE
    Arch Gen Psychiatry; 1968 Jun; 18(6):658-65. PubMed ID: 5651509
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical abnormalities associated with schizophrenia.
    Smythies JR
    Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations concerning the "pink spot" reacting substances in urine.
    Watt JA; Ashcroft GW; Daly RJ; Smythies JR
    Acta Psychiatr Scand; 1970; 46(4):374-90. PubMed ID: 5502783
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary metabolites in Parkinson's disease.
    Kuehl FA; Vandenheuvel WJ; Ormond RE
    Nature; 1968 Jan; 217(5124):136-8. PubMed ID: 5638146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.